NEJM Evidence Issues Research Articles in October 2022 Edition
October 21, 2022
October 21, 2022
WALTHAM, Massachusetts, Oct. 21 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its October 2022 edition:
ORIGINAL ARTICLES:
* Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS
* Endotrophin, a Collagen VI Formation-Derived Peptide, in Heart Failure
* A Randomized Trial of . . .
ORIGINAL ARTICLES:
* Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS
* Endotrophin, a Collagen VI Formation-Derived Peptide, in Heart Failure
* A Randomized Trial of . . .